Atria Investments Inc Sells 413 Shares of Teleflex Incorporated (NYSE:TFX)

Atria Investments Inc decreased its position in shares of Teleflex Incorporated (NYSE:TFX) by 14.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,521 shares of the medical technology company’s stock after selling 413 shares during the quarter. Atria Investments Inc’s holdings in Teleflex were worth $449,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. Apollon Wealth Management LLC lifted its holdings in Teleflex by 3.7% during the 3rd quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock worth $377,000 after buying an additional 55 shares in the last quarter. SRS Capital Advisors Inc. lifted its stake in shares of Teleflex by 0.3% in the 3rd quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock valued at $4,844,000 after purchasing an additional 60 shares during the period. Tokio Marine Asset Management Co. Ltd. lifted its stake in shares of Teleflex by 4.5% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,517 shares of the medical technology company’s stock valued at $375,000 after purchasing an additional 66 shares during the period. HighTower Advisors LLC lifted its stake in shares of Teleflex by 1.7% in the 3rd quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock valued at $986,000 after purchasing an additional 66 shares during the period. Finally, Huntington National Bank lifted its stake in shares of Teleflex by 32.5% in the 3rd quarter. Huntington National Bank now owns 310 shares of the medical technology company’s stock valued at $77,000 after purchasing an additional 76 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. Citizens Jmp downgraded Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday, February 27th. Raymond James downgraded Teleflex from an “outperform” rating to a “market perform” rating in a research note on Friday, February 28th. Truist Financial cut their price target on Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a research note on Monday, March 3rd. Piper Sandler reaffirmed a “neutral” rating and set a $140.00 price objective (down previously from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Finally, Bank of America downgraded Teleflex from a “neutral” rating to an “underperform” rating and dropped their price objective for the stock from $235.00 to $140.00 in a research note on Tuesday, March 4th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $182.63.

Teleflex Price Performance

TFX stock opened at $137.79 on Friday. The stock has a 50-day moving average price of $166.99 and a two-hundred day moving average price of $197.69. The stock has a market cap of $6.39 billion, a PE ratio of 27.39, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 1 year low of $128.55 and a 1 year high of $249.90.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03. The firm had revenue of $795.40 million during the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Equities analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, March 7th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.99%. The ex-dividend date is Friday, March 7th. Teleflex’s dividend payout ratio (DPR) is presently 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.